Skip to main content

Abstract

Objective:

This study aimed to explore the transmission of COVID-19 in a U.S. state psychiatric hospital setting.

Methods:

Symptomatic and asymptomatic patients were tested throughout a large psychiatric hospital to determine penetrance. The hospital followed initial Centers for Disease Control and Prevention (CDC) guidelines.

Results:

Seventy-eight percent (N=51 of 65) of tested patients in the building where the first positive patient was housed (building zero) tested positive for COVID-19. Eighty-eight percent (N=14 of 16) of tested asymptomatic patients in building zero were positive, compared with 12% (N=6 of 51) of randomly selected asymptomatic patients in a sample from the rest of the hospital.

Conclusions:

A high percentage of patients can become positive for COVID-19 despite following initial CDC guidelines. As such, use of masks by all patients in close-quarter settings prior to the first positive case appears warranted. Recent CDC guidelines align with this strategy.

HIGHLIGHTS

Asymptomatic patients who test positive for COVID-19 are highly infectious, but limited data support this finding because most testing is performed on symptomatic patients.
Asymptomatic patients who test positive for COVID-19 are likely adding to high penetrance in close-quarter psychiatric facilities.
Universal masking and higher levels of personal protective equipment (PPE) utilization in these settings prior to the first positive case may be warranted if PPE supply is available.
The description of the COVID-19 crisis and its migration from Wuhan, China, to the United States has been well documented in countless articles. The spread of the virus has been ubiquitous in populations throughout the world (1). People in confined settings, such as prisons and long-term care facilities, have been identified as particularly at-risk populations (2, 3). Furthermore, recent studies have shown that individuals with COVID-19 who are not yet exhibiting symptoms, and even those who never exhibit symptoms, are able to spread the disease (4, 5). As a result of close-quarter housing and asymptomatic transmission, in addition to patient characteristics that make transmission more likely, psychiatric hospitals are particularly vulnerable (6). The focus of this study was to explore the transmission of COVID-19 in a psychiatric inpatient setting, where initial Centers for Disease Control and Prevention (CDC) guidelines were followed.
This study was conducted in a remote psychiatric hospital in the South serving approximately 700 patients. Patients are committed to the hospital by court order because of mental illness and significant legal charges that would lead them to become a danger to the community at large. As such, patients are not easily discharged into the community. The hospital’s units are close quarters with shared restrooms. Twenty to 24 patients are housed on a single unit, and buildings consist of four units.
As the COVID-19 crisis started to infect the U.S. population, the executive team of the hospital began preparing for housing, isolation units, step-down units, and personal protective equipment (PPE) and began halting admissions and discharges. The hospital followed CDC guidelines regarding screening patients and staff in anticipation of the potential impact of COVID-19 on this large mental health population and the equally large staff. All off-campus appointments and new admissions were stopped on March 12, 2020. Beginning on March 13, 2020, all staff were screened with the standard screening questions and temperature checks upon entering the campus. At that time, no patients or staff tested positive or reported common COVID-19 symptoms.
A building was identified that was suitable for isolation, step-down-positive, and step-down-negative patients. Staff were trained to use PPE, including donning and doffing, and to practice isolation techniques. Patients were screened for COVID-19 upon becoming symptomatic (temperature >100.4°F), and those with temperatures of >99.5°F and <100.4°F were monitored for further symptoms. New-onset cough, diarrhea, respiratory complaints, and <93% oxygen saturation were checked on all patients suspected to have symptoms. These patients were rapidly moved to the isolation unit pending test results. A step-down-positive unit was positioned beside the isolation unit in the same building. Patients with negative results were housed on a step-down unit awaiting return to their normal units.
All processes, policies, and procedures were established by a leadership team comprising hospital leaders, state epidemiologists, CDC subject matter experts, and Tulane University infectious disease and epidemiology experts. No decisions were made without general agreement of plans as they emerged.
Patient zero was identified as symptomatic with COVID-19 on March 23, 2020, was tested the next day, and received a positive result on March 26, 2020. Despite the use of rapid isolation, proper PPE, and other measures, individuals in the building where patient zero was housed (building zero) rapidly became infected. Transmission was evident before testing was returned from state lab analysis. When a quarter of the patients on the same unit as patient zero were affected, a decision was made by leadership to shelter in place in building zero. Staff were assigned to this building and were not allowed to work in other buildings. Food was dropped off, and routine lab draws were curtailed or performed outside of the building. All psychiatric and social work visits were performed with telemedicine.
The decision for all patients and staff to wear PPE was made on April 3, 2020, with consensus by a CDC subject matter expert and state epidemiologists. Testing by the state was being reserved for symptomatic patients, which was appropriate at the time. The primary author (J.W.T.) became aware that Tulane University School of Medicine was developing a testing procedure to help increase testing volume. When this testing became available, the author saw an opportunity to test a significant sample of individuals from building zero to determine the penetrance of the virus in that building. Testing was done in consultation with the executive leadership and state epidemiologists and with lab assistance from Tulane. The purpose of this sample was to determine the penetrance of asymptomatic and symptomatic patients in building zero. These data, in conjunction with data on patients’ course of illness, had the potential to warn state officials and hospitals in the catchment area of potential future needs, such as hospital beds and burden on the intensive care unit.

Methods

This study was reviewed by the Tulane University institutional review board and determined to be exempt. Existing, deidentified data analyzed in this study included 160 COVID-19 tests collected from patients in an inpatient psychiatric hospital between March 14 and April 8, 2020. Sixty-eight tests of symptomatic patients were collected using state labs. The Tulane University School of Medicine lab provided an additional 92 tests for a sample of asymptomatic patients by using a CDC 2019 novel coronavirus (2019-nCoV) real-time reverse transcription–polymerase chain reaction (RT-PCR) diagnostic panel (7). By the time the 92 additional patients were tested between April 2 and April 4, 2020, three had become symptomatic, 19 were mildly symptomatic, and 70 remained asymptomatic. Of the 92 additional tests, 41% (N=38) were performed on the remaining patients in building zero who had not yet been tested. The other 59% (N=54) were performed on a random sample of asymptomatic patients throughout three other buildings in the hospital where transmission had recently begun. Patients were randomly selected for testing, excluding those who had already been tested and ensuring that at least one patient was chosen from each unit of the buildings. Analyses were conducted using SPSS, version 24.

Results

A majority of patients in this study were male (N=113, 71%), with a mean±SD age of 51.27±13.91 years (range 23.74–76.36). Two-thirds (N=106, 66%) identified as Black, 33% (N=53) as white, and 1% (N=1) as Hispanic. Results from all 160 tests are presented in Table 1. The positive-to-negative ratio (51:14) of building zero equates to the alarmingly high rate of 78% positive COVID-19 results among clients with valid test results. The positive-to-negative ratio (28:57) of the other buildings sampled showed a much lower rate of positive tests, at 33%. When we examined the 150 valid test results (excluding 10 pending), a chi-square test (with Yates’s continuity correction) indicated that those in building zero were significantly more likely to test positive than were those in other buildings (χ2= 28.82, df=1, p=<0.001, ϕ=0.45).
TABLE 1. COVID-19 test results of symptomatic and asymptomatic patients (N=160) in building of patient zero and all other buildings in a state psychiatric hospital
BuildingNegativePositivePendingTotal
Building zero    
 Asymptomatic214016
 Mildly symptomatic512219
 Symptomatic725335
 Total1451570
All others    
 Asymptomatic456354
 Symptomatic1222236
 Total5728590
The subset of 67 tests of asymptomatic patients who had valid test results (excluding three pending) was further examined. A chi-square test (with Yates’s continuity correction and Fisher’s exact test) indicated that those in building zero were significantly more likely to test positive than were those in other buildings (χ2= 29.84, df=1, p<0.001, ϕ=0.71).

Discussion

These are preliminary data from testing conducted on symptomatic and asymptomatic patients in a state psychiatric hospital where the COVID-19 virus has spread rapidly despite substantial preparation and use of up-to-date CDC guidelines. Results demonstrate that many asymptomatic or mildly symptomatic patients were positive for COVID-19. It appears that CDC guidelines were not sufficient for containing spread in these close-quarter settings.
Although physical distancing is recommended for limiting the spread of COVID-19, such distancing is not possible in close-quarter, confined settings. As such, some state prisons and county jails have decreased bail or released inmates early to decrease spread of the virus. However, given the nature of the offenses of patients in long-term psychiatric settings, combined with their high need for care, releasing patients is not a feasible option. Use of field tents may be a solution for decreasing crowding and increasing physical distance; however, this is not possible in all settings.
Given the difficulties with physical separation, additional measures, such as universal masking, must be taken. Because of the high number of asymptomatic and mildly symptomatic patients who tested positive in this study, waiting to implement masking until the first symptomatic patient tests positive is not recommended. Of course, the limited availability of PPE must be taken into consideration. Another possible preventative measure is to test all staff members who have contact with patients, whether or not they are showing common COVID-19 symptoms. It is possible that asymptomatic staff members may play a role in the introduction or spread of the virus. Unfortunately, with limited testing available, tests are typically reserved for symptomatic patients and staff.
Although the exact source of COVID-19 in the hospital in this study is unknown, hospital administrators suspect that either an asymptomatic staff member introduced the virus or that patient zero was exposed during an off-campus medical appointment that occurred 12 days before he or she became symptomatic and just 1 day before all off-campus appointments were cancelled.
The ability to test asymptomatic patients was a strength of this study and allowed for an estimate of asymptomatic transmission of COVID-19 in close-quarter settings. However, the results should be interpreted with the study’s limitations in mind. Because of limited available testing, not all patients in the hospital were able to be tested. Thus, the penetrance rates provided are estimates based on subsamples.

Conclusions

It is recommended that all close-quarter psychiatric facilities consider using universal masking prior to discovering the initial case of COVID-19. Waiting for positive test results may result in rapid infection by symptomatic and asymptomatic infected patients.

Acknowledgments

The authors appreciate the assistance of Robert Garry, Ph.D., professor of microbiology and immunology at Tulane University School of Medicine, and of Xiao-Ming Yin, M.D., Ph.D., professor and chair of pathology and laboratory medicine at Tulane University School of Medicine, who facilitated and coordinated testing.

References

1.
Coronavirus disease 2019 (COVID-19) Situation Report–81. Geneva, Switzerland, World Health Organization, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200410-sitrep-81-covid-19.pdf?sfvrsn=ca96eb84_2. Accessed April 10, 2020
2.
Kimball A, Hatfield KM, Arons M, et al: Asymptomatic and presymptomatic SARS-CoV-2 infections in residents of a long-term care skilled nursing facility—King County, Washington, March 2020. MMWR Morb Mortal Wkly Rep 2020; 69:377–381
3.
Kinner SA, Young JT, Snow K, et al: Prisons and custodial settings are part of a comprehensive response to COVID-19. Lancet Public Health 2020; 5:e188–e189
4.
Wei WE, Li Z, Chiew CJ, et al: Presymptomatic transmission of SARS-CoV-2—Singapore, January 23–March 16, 2020. MMWR Morb Mortal Wkly Rep 2020; 69:411–415
5.
Li R, Pei S, Chen B, et al: Substantial undocumented infection facilitates the rapid dissemination of novel coronavirus (SARS-CoV2). Science (Epub ahead of print, Mar 16, 2020)
6.
Zhu Y, Chen L, Ji H, et al: The risk and prevention of novel coronavirus pneumonia infections among inpatients in psychiatric hospitals. Neurosci Bull 2020; 36:299–302
7.
CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel. Atlanta, Centers for Disease Control and Prevention, 2020. https://www.fda.gov/media/134922/download

Information & Authors

Information

Published In

Go to Psychiatric Services
Go to Psychiatric Services
Psychiatric Services
Pages: 1285 - 1287
PubMed: 33019856

History

Received: 22 April 2020
Revision received: 27 April 2020
Accepted: 5 May 2020
Published online: 6 October 2020
Published in print: December 01, 2020

Keywords

  1. inpatient services
  2. COVID-19
  3. asymptomatic transmission
  4. penetrance

Authors

Details

John W. Thompson, Jr., M.D. [email protected]
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Amy J. Mikolajewski, Ph.D.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Patricia Kissinger, Ph.D.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Patrick McCrossen, M.D.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Allison Smither, B.S.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Govind Datta Chamarthi, M.B.B.S.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Zhen Lin, M.D., Ph.D.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).
Di Tian, M.D., Ph.D.
Department of Psychiatry and Behavioral Sciences (Thompson, Mikolajewski), Department of Microbiology and Immunology (Smither), and Department of Pathology and Laboratory Medicine (Lin, Tian), Tulane University School of Medicine, New Orleans; Tulane University of School of Public Health and Tropical Medicine, New Orleans (Kissinger, McCrossen); LaCATS–Clinical Translational Unit, New Orleans (Chamarthi).

Notes

Send correspondence to Dr. Thompson ([email protected]).

Competing Interests

The authors report no financial relationships with commercial interests.

Metrics & Citations

Metrics

Citations

Export Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

PDF/EPUB

View PDF/EPUB

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share